Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1224 of 5804
-
New hope for arthritis sufferers? CIT-013 drug trial begins
Disease control Recruiting nowThe goal of this clinical trial is to learn if CIT-013 works to treat rheumatoid arthritis in adults. It will also learn about the safety of CIT-013. The main questions it aims to answer are: Does CIT-013 lower the disease activity of RA patients? What medical problems do partic…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New breathing technique aims to cut lung risks in obesity surgery
Prevention Recruiting nowThis study is a prospective, single-center, single-blind, randomized controlled clinical trial. Patients scheduled for laparoscopic bariatric surgery will be selected and randomly assigned to either the EIT-guided individualized PEEP group (Group P-eit) or the control group (Grou…
Phase: NA • Sponsor: Jianbo Wu • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
New hope for kidney disease: Zigakibart's Long-Term safety under study
Disease control Recruiting nowThe purpose of this study is to determine if zigakibart is safe and effective for long-term use in patients with immunoglobulin A nephropathy (IgAN). This is an extension study for patients who have already completed an another zigakibart study.
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New gentle chemo combo after transplant aims to stop leukemia relapse
Disease control Recruiting nowThe goal of this interventional clinical trial is to determine if low doses of gentle chemotherapy after bone marrow transplant may prevent relapse and promote an increase in survival and decrease in side effects in participants with acute myeloid leukemia and myelodysplastic syn…
Phase: PHASE1, PHASE2 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Poop pills aim to stamp out superbugs in the gut
Disease control Recruiting nowThe goal of this clinical trial is to learn if oral capsules containing lyophilized stool from healthy donors (fecal microbiota transplantation or FMT) can safely and effectively decolonize multidrug-resistant organisms (MDROs) from the intestines in adults. The main questions it…
Phase: PHASE1, PHASE2 • Sponsor: University of Rijeka • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to tame back inflammation in axial spondyloarthritis
Disease control Recruiting nowGRWD0715 is an orally administered, selective inhibitor of the Endoplasmic Reticulum Aminopeptidase 1 \[ERAP1\] enzyme being explored as a potential new treatment for axial spondyloarthritis (axSpA), a long term condition caused by inflammation predominantly affecting the sacroil…
Phase: PHASE1, PHASE2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug hope for Tough-to-Treat colorectal cancer
Disease control Recruiting nowThe goal of this clinical research study is to learn if ivonescimab can help to control previously treated, metastatic colorectal cancer.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for myelofibrosis: drug combo targets tough cases
Disease control OngoingThis is a Phase Ib/II clinical study to evaluate the safety , efficacy and pharmacokinetics of WJ01024 tablets combined with Ruxolitinib tablets in patients with myelofibrosis.The study will be conducted in two phases: Phase 1b and Phase 2.Phase Ib is a dose extension study of WJ…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Junjing BioSciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
AI chatbot could calm nerves before prostate surgery
Symptom relief OngoingThe goal of this clinical trial is to evaluate the efficacy of large language model (LLM)-assisted communication on psychological distress alleviation and healthcare efficiency improvement in prostate cancer patients. The main questions it aims to answer are: Does LLM-assisted c…
Phase: NA • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Could cold plasma be the next acne breakthrough?
Disease control Recruiting nowAcne vulgaris is a common, chronic inflammatory skin disease with complex pathogenesis and limited therapeutic options, especially for moderate-to-severe cases. Standard treatments-including topical and oral agents-are often constrained by side effects, antimicrobial resistance, …
Phase: NA • Sponsor: Shenyang Medical College • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New drug targets KRAS mutations in advanced cancers
Disease control Recruiting nowGenes contain genetic code which tell the body which proteins to make. Many types of cancer are caused by changes, or mutations, in a gene called KRAS. Researchers are looking for ways to stop the actions of abnormal proteins made from the mutated KRAS gene. ASP5834 is being stu…
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New pill RAP-219 aims to tame mania in bipolar disorder
Symptom relief Recruiting nowThis is a clinical research study for an investigational drug called RAP-219 in participants with bipolar I disorder. This study is being conducted to determine if RAP-219 is safe and effective in participants experiencing mania associated with bipolar I disorder.
Phase: PHASE2 • Sponsor: Rapport Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New diabetes drug HRS9531 aims to improve blood sugar control in phase 3 trial
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy and safety of HRS9531 compared with placebo in participants with type 2 diabetes mellitus not adequately controlled with basal insulin, with or without metformin and/or sodium-glucose cotransporter-2 (SGLT2) inhibitor. The stu…
Phase: PHASE3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New cell therapy combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis purpose of this clinical trial is to evaluate the safety, tolerability and anti-tumor activity of IMA203 in combination with different doses of mRNA-4203. The trial includes participants with previously treated unresectable or metastatic cutaneous melanoma (CM) or synovial s…
Phase: PHASE1 • Sponsor: Immatics US, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Breathing Tube-Free lung surgery may be gentler on lungs and the planet
Disease control CompletedThis prospective cohort study evaluates lung injury, long-term clinical outcomes, and environmental impacts of tubeless video-assisted thoracic surgery (VATS) compared with conventional intubated VATS for lung cancer resection. The study aims to determine whether the tubeless app…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can first responders save more lives in cardiac arrest? new study investigates
Knowledge-focused ENROLLING_BY_INVITATIONREVIVE Zug: Improving Emergency Response for Out-of-Hospital Cardiac Arrest Out-of-hospital cardiac arrest (OHCA) represents one of the most time-critical medical emergencies, where rapid recognition and immediate intervention are decisive for survival and neurological outcome. …
Sponsor: Felix Brinkmann • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Promising melanoma combo trial halted early – only one patient enrolled
Disease control TerminatedThe goal of this clinical trial is to learn about the effectiveness and safety of the bispecific antibody acasunlimab (also known as DuoBody®-PD-L1x4-1BB) when given either alone or together with the cancer drug pembrolizumab in participants with locally advanced or metastatic me…
Phase: PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Mushroom extract tested to stop lung infection relapse
Prevention Recruiting nowThe goal of this clinical trial is to learn if cordyceps sinesis capsule (Bailiing Capsule) works to prevent the recurrence of microbiologically cured mycobacterium avium complex pulmonary disease in adults. The main questions it aims to answer are: Does cordyceps sinesis capsul…
Phase: PHASE4 • Sponsor: Bin Cao • Aim: Prevention
Last updated Jun 26, 2026 17:15 UTC
-
Smartwatch study aims to Fine-Tune Parkinson's medication timing
Disease control Recruiting nowThe purpose of this study is to evaluate the effect of IPX203 (Crexont®) - the newest extended-release levodopa formulation - on the duration and quality of good on time, using a wearable device to monitor symptoms. 'Good on time' refers to a period (minutes to hours) when a pati…
Phase: PHASE4 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New anemia pill for dialysis patients tested against standard shots
Disease control OngoingThis is a multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the efficacy of vadadustat administered three times a week compared to standard of care erythropoiesis-stimulating agent for the treatment of anemia in in-center hemodialysis participants …
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC